OPRX raised guidance after record Q1 EBITDA, but pharma budget shifts and margin mix pose new challenges ahead.

RH eyes 20-21% EBITDA margin in FY25 as global growth, sourcing shifts and pricing moves offset housing headwinds.

RH eyes 20-21% EBITDA margin in FY25 as global growth, sourcing shifts and pricing moves offset housing headwinds.

CCL's yield gains and onboard spend surge lift fiscal second-quarter margins, prompting a boost to FY25 EBITDA guidance.

Sprouts Farmers sees 11.7% comp sales surge in Q1, but guidance points to slower growth in the coming quarters.

India continues to maintain its crown as the world’s top recipient of diaspora remittances, with inflows hitting a record $135.46 billion in the...

India continues to maintain its crown as the world’s top recipient of diaspora remittances, with inflows hitting a record $135.46 billion in the...

Intuitive Surgical raises 2025 procedure outlook after strong Q1 growth, but rising costs and tariff pressure weigh on margins.

AXON lifts 2025 EBITDA outlook as strong TASER and body cam sales drive margin gains despite rising costs.

The Agriculture - Operations industry is gaining from healthy eating trends, innovation and global demand, but rising costs and trade risks pose...